United States · FDA National Drug Code directory
BUPRENORPHINE AND NALOXONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-607_f06091b6-2823-40db-bf86-e56a86db4532
- Product NDC
- 67877-607
- Form
- TABLET
- Composition / generic term
- BUPRENORPHINE AND NALOXONE
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260703
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 2 mg/1
- NALOXONE HYDROCHLORIDE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (67877-607-30) · 67877-607-30
- 3 BLISTER PACK in 1 CARTON (67877-607-84) / 10 TABLET in 1 BLISTER PACK · 67877-607-84
- 90 TABLET in 1 BOTTLE (67877-607-90) · 67877-607-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →